mbi-226 and Aspergillosis

mbi-226 has been researched along with Aspergillosis* in 1 studies

Other Studies

1 other study(ies) available for mbi-226 and Aspergillosis

ArticleYear
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Omiganan, a bactericidal and fungicidal cationic peptide being developed as a topical gel for prevention of catheter-associated infections, inhibited commonly occurring fungal pathogens including Candida spp. (106 isolates) at

    Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests

2008